These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10211085)

  • 1. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
    van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
    Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
    Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
    Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
    Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen.
    Kontos M; Allen DS; Agbaje OF; Hamed H; Fentiman IS
    Eur J Surg Oncol; 2011 Dec; 37(12):1051-8. PubMed ID: 21843919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
    van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
    Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving therapy: a viable option for young women with early breast cancer--evidence from a prospective study.
    Xie Z; Wang X; Lin H; Wei W; Liu P; Xiao X; Xie X; Guan X; Yang M; Tang J
    Ann Surg Oncol; 2014 Jul; 21(7):2188-96. PubMed ID: 24599412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
    van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Tong D; Winter J
    Eur J Cancer; 1992; 28A(4-5):801-5. PubMed ID: 1524898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study.
    Elkhuizen PH; van Slooten HJ; Clahsen PC; Hermans J; van de Velde CJ; van den Broek LC; van de Vijver MJ
    J Clin Oncol; 2000 Mar; 18(5):1075-83. PubMed ID: 10694560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast conserving treatment versus modified radical mastectomy in Japanese patients with operable breast cancer.
    Noguchi M; Yagasaki R; Kawahara F; Minami M; Tsuyama H; Earashi M; Kinoshita K; Taniya T; Miwa K; Nishijima H; Takanaka T; Kawashima H; Takashima C; Kanno M; Nakamura S; Mizukami Y; Nonomura A; Michigishi T; Yokoyama K
    Int Surg; 1997; 82(3):289-94. PubMed ID: 9372377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
    de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
    Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort.
    Lyngholm CD; Laurberg T; Alsner J; Damsgaard TE; Overgaard J; Christiansen PM
    Acta Oncol; 2016 Aug; 55(8):983-92. PubMed ID: 27120011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy.
    Fentiman IS; Christiaens MR; Paridaens R; Van Geel A; Rutgers E; Berner J; de Keizer G; Wildiers J; Nagadowska M; Legrand C; Therasse P;
    Eur J Cancer; 2003 Feb; 39(3):309-16. PubMed ID: 12565982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).
    Curran D; van Dongen JP; Aaronson NK; Kiebert G; Fentiman IS; Mignolet F; Bartelink H
    Eur J Cancer; 1998 Feb; 34(3):307-14. PubMed ID: 9640214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast conservative therapy in east part of China: a retrospective cohort study.
    Fan J; Wang L; Wang XJ; Wu J; Lu JS; Di GH; Shen KW; Han QX; Liu BL; Shen ZZ; Shao ZM
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):573-8. PubMed ID: 16741727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local-regional control in breast cancer patients with a possible genetic predisposition.
    Freedman LM; Buchholz TA; Thames HD; Strom EA; McNeese MD; Hortobagyi GN; Singletary SE; Heaton KM; Hunt KK
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):951-7. PubMed ID: 11072150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term age-dependent failure pattern after breast-conserving therapy or mastectomy among Danish lymph-node-negative breast cancer patients.
    Laurberg T; Lyngholm CD; Christiansen P; Alsner J; Overgaard J
    Radiother Oncol; 2016 Jul; 120(1):98-106. PubMed ID: 27289261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
    Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
    Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifen.
    Fentiman IS; van Zijl J; Karydas I; Chaudary MA; Margreiter R; Legrand C; Therasse P;
    Eur J Cancer; 2003 Feb; 39(3):300-8. PubMed ID: 12565981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is mastectomy superior to breast-conserving treatment for young women?
    Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.